[{"Assets_0_Q2_USD":138012000.0,"CommonStockSharesOutstanding_0_Q2_shares":62680390.0,"NetIncomeLoss_1_Q2_USD":-23377000.0,"NetIncomeLoss_2_Q2_USD":-44061000.0,"StockholdersEquity_0_Q2_USD":129152000.0,"Ticker":"IOVA","CIK":"1425205","name":"IOVANCE BIOTHERAPEUTICS, INC.","OfficialName":"Iovance Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2593277297.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]